Gary Kurtzman

Gary J.
Kurtzman is currently the Chairman at Prognos Health, Inc., Chairman at Oncora Medical, Inc., Director at Quantia, Inc., Director at Dabo Health, Inc., Director at Velano Vascular, Inc. (since 2018), and Lecturer at the University of Pennsylvania.
He is also a Senior Advisor at Safeguard International Management LLC (since 2021).
Previously, Dr. Kurtzman served as the Chief Executive Officer at Pluvita Corp from 2001 to 2004.
He was also the Chairman at Alverix, Inc. from 2009 to 2014, Chairman at Syapse, Inc., Senior VP & Managing Director-Life Sciences Group at Safeguard Scientifics, Inc. from 2011 to 2013, Independent Director at Tengion, Inc. in 2011, Director at Neuronyx, Inc., Director at Shire Regenerative Medicine, Inc., Director at Crescendo Bioscience LLC, Director at Avid Radiopharmaceuticals, Inc., Director at PixelOptics, Inc., Director at Molecular Biometrics, Inc. from 2000 to 2012, Independent Director at NuPathe, Inc. in 2011, Director at New Life Solution, Inc., Chief Operating Officer & Managing Director at The Biotechnology Greenhouse Corp.
of Southeastern PA in 2006, Director at Garnet BioTherapeutics, Inc., Director at Good Start Genetics, Inc. from 2010 to 2017, Director at Aktana, Inc., and Director at Trice Medical, Inc. from 2014 to 2022.
Dr. Kurtzman started his career as the Virology Group Leader at Gilead Sciences, Inc. from 1991 to 1993.
He then served as the Vice President-Research & Development at Avigen, Inc. from 1993 to 1998 and as the Chief Operating Officer at Genovo, Inc. from 1998 to 2001.
Dr. Kurtzman received his undergraduate and doctorate degrees from Stanford University in 1977.
He also holds a doctorate degree from the University of Washington.